Dr Burr is a Clinical Research Fellow at the University of Leeds, and final year Specialist Registrar. He has been a clinical academic trainee in Yorkshire since moving from East Anglia in 2014. HIs main clinical and academic interests are Inflammatory Bowel Diseases and Colorectal Cancer.

Dr Burr has tried to answer clinically relevant questions with the use of population-level data, and evidence synthesis using meta-analysis. With the academic team in Leeds, we have developed a protocol for network meta-analysis. This gives a ranking or hierarchy of treatments which may not have been compared “head-to-head” in a clinical trial. We have published several articles in Gut, Gastroenterology and the Lancet Gastroenterology and Hepatology recently.

Shahida Din is a Consultant Gastroenterologist at the Western General Hospital in Edinburgh and a National Research Scotland Clinician leading clinical trials and a programme of work to improve the detection of colonic epithelial dysplasia/colorectal cancer in patients with inflammatory bowel diseases. Shahida is leading a Scottish Government led working group to standardise IBD Surveillance procedures.
In 2019, Shahida was jointly awarded a Helmsley Charitable Trust Grant to develop the Crohn’s Disease Gut Cell Atlas with her collaborators in Edinburgh and Cambridge. Shahida is a member of the BSG IBD Committee and Gastroenterology specialty advisor to the RCPE and lead author of the adaptations of the BSG ASUC guidelines and clinical service recovery during the pandemic.

Aileen Fraser, an IBD Advanced Clinical Practitioner, leads the IBD nursing service University Hospitals Bristol, where she has been in post since 2001. She has an MSc in advanced practice in healthcare, completing this with a dissertation on sexual dysfunction in pouch patients In addition to her clinical practice, Aileen has also made contributions to IBD research and was a member of the BSG IBD committee involved in writing the 2019 BSG IBD Clinical Guidelines. She was also one of the authors of the 2007 IBD nurse role descriptives document.

Since taking up post as the IBD CNS for the trust Aileen has been active within the IBD nurse community, chairing the Severnside regional IBD nurse group and having been secretary and now current for the RCN national IBD nurse group . She was also previously an RCN IBD Forum representatives on the BSG IBD Section Committee.

Her other interests include managing patient expectations, transition of young patients, pregnancy, iron deficiency and the effect of insomnia on fatigue levels in the IBD community.

Dr Nick Kennedy (MBBS FRACP MA Hons) is a Consultant Gastroenterologist at the Royal Devon and Exeter Hospital, and Honorary Clinical Senior Lecturer at the University of Exeter. He obtained his Ph.D. in Medicine at The University of Edinburgh.

His clinical and research interests are in inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis), particularly in understanding treatment response in IBD. He has coordinated large multi-site research projects to assess the contributions of genetics, epigenetics, and the gut microbiota to the development, progression, and treatment response in IBD.

He is a member of the UK and international IBD genetics consortia, sits on the British Society of Gastroenterology (BSG) IBD clinical research and guidelines groups, and is an associate editor of Alimentary Pharmacology & Therapeutics. He is a key author of the BSG guidance and risk assessment for IBD patients during the COVID-19 pandemic and has conducted several studies to help understand the impact of IBD and its treatments on COVID-19.

Dr Klaartje Bel Kok, MBBM MRCP PhD trained at the AMC, Amsterdam, and studied for a PhD at UCL (Ludwig Institute), London. She now works as a Consultant Gastroenterologist at Barts Health, the Royal London Hospital where she is a core member of the IBD team. Her interests include IBD, IBD in young adults and pregnancy, as well as intestinal failure. Bel sits on the United European Gastroenterology Education committee and has a number of publications and book chapters in the field of IBD and she reviews papers for several journals. She is a Honorary Senior Clinical Lecturer at Queen Mary University of London and is a chief investigator for IBD translational research and investigator led clinical trials.

Charlie is Professor of Gastroenterology at the University of Edinburgh, a UK Research and Innovation Future Leaders Fellow (UKRIFLF) and Consultant Gastroenterologist in the Edinburgh IBD Unit.

In 2019 Charlie was awarded the UKRIFLF, a personal fellowship worth £1.7m that enabled his transition to full-time academic gastroenterology. His core mission is to improve outcomes for people living with IBD and together with his team, is working on predicting outcomes in IBD through the PREdiCCt study where he is the Chief Investigator. In addition to predicting outcomes, Charlie is integrating health apps and working with industry partners to disrupt IBD care through digital technologies and data driven innovation.

Charlie is a passionate educator lecturing widely about the current and future management of IBD, the causes and consequences of IBD, telemedicine and digital health.

Lisa is an IBD Nurse Consultant working at St Marks Hospital. She has over 15 years’ experience working as an inflammatory bowel disease nurse specialist and has been responsible for the creation of and subsequent development of IBD nursing services at a number of London hospitals prior to taking up her current post.

Lisa completed her nurse training at the North London College of Health Studies, London, UK, and has subsequently completed an MSc in Advanced Nursing Practice, undertaking an audit of satisfaction levels with service delivery amongst older people living with IBD.

Her publications include journal articles and chapters on topics including IBD treatment and the contribution of specialist nurses to the management and support of patients with inflammatory bowel disease, and she is actively involved with the education of both pre and post registration nurses regarding management of IBD. She has served as a committee member on the Royal College of Nursing IBD Special Interest group, British Society of Gastroenterology IBD Section and NECCO, including 5 years as the Chair of NECCO from 2008 ‐ 2013.

In March 2019 she started working with Crohn’s and Colitis UK for two days a week as Project Manager, IBD nursing, and is currently one of the Royal College of Nursing representatives in IBDUK, an organisation committed to standardising care for people with IBD throughout the UK.